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Abstract20
Imbalances in the oral microbial community have been associated with reduced 21
cardiovascular and metabolic health. A possible mechanism linking the oral microbiota to 22
health is the nitrate (NO3
-
)-nitrite (NO2
-
)-nitric oxide (NO) pathway, which relies on oral 23
bacteria to reduce NO3
- 
to NO2
-
. NO (generated from both NO2
-
 and L-arginine) regulates 24
vascular endothelial function and therefore blood pressure (BP). By sequencing bacterial 16S 25
rRNA genes we examined the relationships between the oral microbiome and physiological 26
indices of NO bioavailability and possible changes in these variables following 10 days of 27
NO3
-
 (12 mmol/d) and placebo supplementation in young (18-22 yrs) and old (70-79 yrs) 28
normotensive humans (n=18). NO3
-
 supplementation altered the salivary microbiome 29
compared to placebo by increasing the relative abundance of Proteobacteria (+225%) and 30
decreasing the relative abundance of Bacteroidetes (-46%; P<0.05). After NO3
-
31
supplementation the relative abundances of Rothia (+127%) and Neisseria (+351%) were 32
greater, and Prevotella (-60%) and Veillonella (-65%) were lower than in the placebo 33
condition (all P<0.05). NO3
-
 supplementation increased plasma concentration of NO2
-
 and 34
reduced systemic blood pressure in old (70-79 yrs), but not young (18-22 yrs), participants. 35
High abundances of Rothia and Neisseria and low abundances of Prevotella and Veillonella36
were correlated with greater increases in plasma [NO2
-
] in response to NO3
-
 supplementation. 37
The current findings indicate that the oral microbiome is malleable to change with increased 38
dietary intake of inorganic NO3
-
, and that diet-induced changes in the oral microbial 39
community are related to indices of NO homeostasis and vascular health in vivo. 40
41
Keywords: Ageing; cardiovascular health; oral nitrate reduction; nitrite; 16S rRNA 42
sequencing; host-microbe symbiosis; prebiotic. 43
44
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Introduction45
46
Inorganic nitrate (NO3
-
) is a natural part of the human diet that is found in high 47
concentrations in many vegetables. NO3
-
 itself is biologically inert and human cells are 48
believed to lack NO3
-
-reductase capability. However, commensal bacteria in the oral cavity 49
can use nitrate as a terminal electron acceptor for ATP synthesis, reducing NO3
-
 to nitrite 50
(NO2
-
; which can be vasoactive in low-oxygen and low-pH conditions) and this NO2
-
 can be 51
further reduced to the potent vasodilator, nitric oxide (NO) (Dejam et al. 2004). The NO3
-
-52
NO2
-
-NO reduction pathway underpins the discovery that dietary NO3
-
supplementation53
through consumption of NO3
-
salts (Larsen et al. 2006) or vegetable products such as beetroot 54
juice (Kelly et al. 2013a; Webb et al. 2008) reduces blood pressure (BP) in healthy young and 55
old humans.56
57
The importance of a functioning oral microbiome for the NO3
-
- NO2
-
-NO reduction pathway58
is highlighted in cases where use of antibacterial mouthwash markedly blunts the increase in 59
plasma and saliva NO2
-
concentrations and associated decrease in BP following ingestion of a 60
standardised NO3
-
dose (Govoni et al. 2008; Kapil et al. 2013; McDonagh et al. 2015). 61
Epidemiological studies also indicate that dysbiosis of the oral microbial community is 62
associated with poor cardiovascular health (Briskey et al. 2016). Conversely, a diet rich in 63
vegetables, which contain high concentrations of inorganic NO3
-
, significantly protects64
against both coronary heart disease and stroke (Bondonno et al. 2017; Hung et al. 2004; 65
Joshipura et al. 2009). Ageing has been associated with reduced salivary flow rate (‘dry 66
mouth’) and altered oral bacterial colonisation (Percival et al. 1991; Xu et al. 2015), but it is 67
not known whether the abundances of NO3
-
reducing oral bacteria decline with age. Dietary 68
NO3
-
intake, and the abundance of NO3
-
-reducing oral bacteria, therefore represent routes to 69
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lower blood pressure and maintain and improve cardiovascular health across the human 70
lifespan. 71
72
It is possible that dietary NO3
-
as a prebiotic treatment might promote proliferation of NO3
-
73
reducing bacteria. In a rodent model, a NO3
-
-rich diet over 7 days increased abundance of 74
oral bacteria (Streptococcus and Haemophilus) that contain NO3
-
reductase genes (Hyde et al. 75
2014a). In saliva samples of hypercholesterolaemic humans, 6 weeks of NO3
-
76
supplementation with beetroot juice significantly increased the abundance of Neisseria 77
flavescens and tended to increase Rothia mucilaginosa which are known NO3
-
reducers78
(Velmurugan et al. 2016). These studies indicate that increased dietary NO3
-
intake may alter 79
the oral microbiome in a way which enhances an individual’s ability to reduce ingested NO3-, 80
resulting in greater plasma NO2
-
concentration and a greater reduction in systemic blood 81
pressure. However, characterisation of potential changes in the oral microbiome of healthy 82
young and old humans in response to NO3
-
supplementation is lacking.83
84
In the present study, we used 16S rRNA gene sequencing to investigate whether abundances 85
of NO3
-
-reducing bacteria on the surface of the human tongue modulate an individual’s 86
response to NO3
-
supplementation in young (18-22 years) and old (70-79 years) normotensive 87
adults. We hypothesised that at baseline, abundances of known NO3
-
-reducing bacteria88
(including Neisseria, Prevotella, Rothia, Veillonella and Actinomycetales) would be greater 89
in young compared to old participants, and that high abundances of these bacteria at baseline 90
would be associated with higher plasma NO2
-
concentrations, and greater changes in blood 91
pressure and arterial stiffness in response to NO3
-
supplementation. Secondly, we investigated92
whether 10 days of regular dietary NO3
-
ingestion altered the oral microbiome compared with93
placebo supplementation. It was hypothesised that oral microbiomes would be different 94
5 
between placebo and NO3
-
 conditions, and specifically that the relative abundances of 95
bacteria capable of NO3
-
 reduction would be greater after NO3
-
 compared to placebo 96
supplementation. 97
98
Methods99
100
Ethical approval 101
The study was approved by the institutional Ethics Committee (Sport and Health Sciences, 102
University of Exeter) and conducted in accordance with the code of the ethical principles of 103
the World Medical Association (Declaration of Helsinki). All participants gave their written, 104
informed consent before the commencement of the study, once the experimental procedures, 105
associated risks, and potential benefits of participation had been explained.  106
107
Study participants108
Nine old adults including six females (mean ± SD, age 75 ± 3 yrs, age range 70-79 yrs, height 109
162 ± 6 cm, body mass 61.8 ± 14.0 kg) and three males (age 73 ± 5 yrs, age range 70-78 yrs, 110
height 172 ± 4 cm, body mass 77.7 ± 11.6 kg) and nine young adults including five females 111
(age 20 ± 1 yrs, age range 19-22 yrs, height 168 ± 7 cm, body mass 67.9 ± 10.3 kg) and four 112
males (age 20 ± 2 yrs, age range 18-22 yrs, height 180 ± 4 cm, body mass 73.4 ± 12.9 kg) 113
volunteered to participate in this study (Table 1). All participants were of Caucasian 114
ethnicity. The nine old adults represented a subsample of a larger cohort tested for a Dunhill 115
Medical Trust funded project (R269/1112) from which the microbiome of the tongue and 116
saliva were retrospectively analysed. Participants were screened prior to participation to 117
ensure suitability for the study. All participants were ostensibly healthy and were not taking 118
medication or dietary supplements. None of the participants were tobacco smokers and all 119
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reported having no oral diseases. Participants were instructed to arrive at the laboratory in a 120
rested and fully hydrated state, at least 3 h postprandial, and to avoid strenuous physical 121
exertion in the 24 h preceding each laboratory visit. Participants were also asked to refrain 122
from caffeine and alcohol intake 6 and 24 h before each test, respectively. All tests were 123
performed at approximately the same time of day (± 2 h) for each participant. 124
125
Experimental design 126
Prior to commencing dietary supplementation, participants visited the laboratory for health 127
screening and familiarisation to test protocols. Participants completed a salivary flow rate 128
questionnaire (SFR-Q; Fox et al. 1987). The SFR-Q included eleven questions asking the 129
participant to rate the frequency of various symptoms of low salivary flow rate on a scale of 1 130
(‘never’) to 5 (‘very often’). Participants then underwent two 10-day dietary supplementation 131
periods with NO3
-
 and placebo in a randomised, double-blind, cross-over design (Figure 1). 132
On days 8, 9 and 10 of each supplementation period, participants returned to the laboratory. 133
Upon arrival at the laboratory on days 8, 9 and 10 venous blood samples were collected for 134
the measurement of plasma [NO2
-
] and [NO3
-
] and resting BP was measured. The mean 135
values of three measurements of [NO2
-
], [NO3
-
] and BP were used for further analyses. Saliva 136
samples were also collected on each visit and three samples were pooled for analysis of the 137
salivary microbiome. Arterial stiffness was assessed on one occasion (day 8, 9 or 10) using 138
radial-femoral pulse wave velocity (PWV). 139
140
Supplementation 141
The supplements were NO3
- 
-rich concentrated beetroot juice (BR) (2 x 70 ml∙d-1, each 70 ml142
containing ~6.2 mmol NO3
-
; Beet It, James White Drinks, Ipswich, UK) and NO3
-
-depleted143
concentrated beetroot juice placebo (PL) (2 x 70 ml·d
-1
, each 70 ml containing ~0.01 mmol 144
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NO3
- 
; Beet It, James White Drinks, Ipswich, UK). The PL was indistinguishable from the BR 145
supplement in appearance, taste and smell. Participants were instructed to consume one 70-ml 146
beverage in the morning and one in the afternoon. On testing days, participants were asked to 147
ingest one 70-ml beverage in the morning and one 2.5 h prior to their laboratory visit. A 148
washout period of at least three days and up to 47 days separated the supplementation 149
periods. Participants were instructed to maintain their normal daily activities, food intake and 150
oral hygiene regime throughout the study. However, participants were instructed to refrain 151
from using antibacterial mouthwash during the study period. Participants were advised that 152
supplementation may cause beeturia (red urine) and red stools temporarily, but that such side 153
effects were harmless.154
155
Oral bacteria 156
Oral swabs of the tongue dorsum were collected at baseline. Saliva samples (~ 1 mL) were 157
collected by expectoration, without stimulation, over a period of 5 min on three occasions 158
following PL and BR supplementation periods. Oral swab and saliva samples were stored at -159
80°C until analysis. Genomic DNA was isolated from tongue swabs using a Gentra Puregene 160
Buccal Cell Kit (Qiagen, Germantown, MD), and from saliva samples following the methods 161
of Goode et al. (2014). Double-stranded DNA concentration was fluorometrically quantified 162
(Qubit 3.0 high-sensitivity fluorescence detection, ThermoFisher Scientific, Waltham, MA). 163
Library preparation employed a NEXTflex 16S V1-V3 Amplicon-Seq Kit (Bioo Scientific, 164
Austin, USA). The 16S V1-V3 rDNA region was amplified using 5ng of dsDNA and 165
subjected to 8 thermal cycles of 30 s at 98°, 30 s at 60° and 30 s at 72° with primers A and B 166
(Table S1). Following AMPure® XP bead cleanup (Becton Dickinson, Franklin Lakes, NJ), a 167
subsequent PCR with indexing primers to identify individual samples, containing Illumina 168
flow cell binding sites, was performed.  169
8 
170
The samples were sequenced using paired-end 300 base pair (bp) MiSeq Illumina platform 171
(Illumina, San Diego, CA) using v3 MiSeq reagents. For each sample, the nucleotide 172
sequence data in FASTQ format was trimmed using Trim-Galore! (Krueger F. Trim-Galore!, 173
accessible at http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/). Quality 174
trimming was performed by removing low-quality bases from the 3’ read ends. The adapter 175
sequences were subsequently removed from the 3’ end (the first 13 base pairs). Trim-Galore! 176
paired-end validation was performed to remove short sequences once the trimming was 177
complete, where the minimum specified length was 20 bp. The bacterial taxonomies and 178
abundance were assigned using Kraken standard build, which uses the genomes in Refseq 179
and NCBI taxonomic information (Kraken manual, accessible at: 180
http://ccb.jhu.edu/software/kraken/MANUAL.html#kraken-databases). The paired read 181
sequences were classified and processed by the Kraken Taxonomic Sequence Classification 182
System (Woods and Salzberg 2014). Variations in the V1-V3 regions enabled NCBI 183
taxonomic identification, and kraken-translate was used to translate the NCBI Identifiers to 184
taxonomy identifiers. A Kraken report was generated for each sample, which was visualised 185
using Krona bioinformatics pie charts (Ondov et al. 2011).  186
187
Plasma [NO3
-
] and [NO2
-
]  188
Blood samples for determination of plasma [NO2
-
] and [NO3
-
] were collected from an 189
antecubital vein into lithium heparin tubes and centrifuged for 8 min at 3000 g and 4 °C 190
within 2 min of collection. Plasma was extracted and samples stored at -80°C for later 191
determination of [NO3
-
] and [NO2
-
] using a modified chemiluminescence technique as 192
previously described (Kelly et al. 2013a).  193
194
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Blood pressure and arterial stiffness 195
Blood pressure of the brachial artery was measured following 10 min of seated rest in a quiet 196
room using an automated sphygmomanometer (Dinamap Pro, GE Medical Systems, Tampa, 197
USA). A total of four measurements were taken, with the mean of the final three 198
measurements recorded. The mean of the systolic (SBP), diastolic (DBP) and mean arterial 199
pressure (MAP) measurements made over three laboratory visits in each condition were 200
calculated for each individual and used for subsequent analyses. Arterial stiffness was 201
estimated via pulse-wave velocity (PWV) (Complior SP; Alam Medical, Vincennes, Paris, 202
France). Electrodes were placed on the carotid, femoral, and radial arteries, and the pulse 203
transit time was calculated and recorded. A mean of three measurements was calculated and 204
used for subsequent analyses. The position of each electrode was measured in relation to the 205
nearest bony landmark to enable precise reproduction of the position of the electrodes in each 206
condition. 207
208
Statistical analyses 209
The Kraken raw data output of phylogenetic data were analysed using R-script (R 210
Development Core Team 2008), SPSS V20 and Microsoft Excel. Non-metric 211
multidimensional scaling (NMDS) was used to assess the level of microbiome similarity 212
between young and old, and PL and BR conditions using non-parametric relationships, and 213
analysed using ADONIS (Vegan R Software). Differences between PL and BR conditions 214
were assessed using paired t-tests with Bonferroni-Hoechberg correction on bacteria that 215
made up >0.01% of bacteria (R statistical software). The Shannon-Wiener diversity index 216
(H’) was used to explore differences in diversity (Vegan R Software). Paired-samples t-tests 217
were used to assess differences between BR and PL conditions in plasma [NO2
-
] and [NO3
-
], 218
BP and arterial stiffness. Relationships between plasma NO biomarkers, oral microbiome and 219
10 
physiological responses to supplementation were assessed using Pearson’s correlation 220
coefficients. Statistical significance was accepted when P<0.05 and statistical trend was 221
defined as P<0.10. Data were expressed as mean ± SD. 222
223
Results 224
225
The young and old participants were similar in terms of body mass and BMI (Table 1). The 226
young participants had a greater mean score in SFR-Q than the old participants (Table 1), 227
indicative of more frequent self-reported symptoms of low salivary flow rate. The young 228
participants reported greater frequency of sensations associated with dry mouth (old 1.6 ± 229
1.0, young 2.7 ± 0.5; P<0.05) and having difficulty eating dry foods (old 1.1 ± 0.3, young 1.8 230
± 0.4; P<0.05).   231
232
NO biomarkers, blood pressure and arterial stiffness  233
The NO3
-
 dose relative to body mass was not different between young and old participants, 234
but the latter had a greater increase in plasma [NO2
-
] in response to BR supplementation 235
(Table 1). Plasma [NO3
-
] and [NO2
-
] were significantly higher following BR supplementation 236
compared with PL (all P<0.05; Figure 2, panels A and B). BR supplementation increased 237
plasma [NO3
-
] relative to PL by a similar amount in old (1509 ± 744%) and young 238
participants (1481 ± 909%) (Figure 2C), but the increase in [NO2
-
] was greater in old (648 ± 239
477%) compared to young participants (365 ± 249%, P<0.05; Figure 2D). There were no 240
differences between young and old participants in plasma [NO3
-
] in PL (old: 28 ± 12 μM, 241
young: 28 ± 14 μM; P>0.05) or BR conditions (old: 379 ± 55 μM, young: 366 ± 101 μM; 242
P>0.05). Plasma [NO2
-
] tended to be greater in the old in PL (old: 173 ± 97 nM, young: 104 ± 243
11 
63 nM; P=0.09) and was significantly greater in the old than young participants in the BR 244
condition (old: 1029 ± 393 nM, young: 380 ± 175 nM; P<0.05).  245
246
MAP, SPB, DBP and PWV were not different between PL and BR conditions across all 247
participants (n=18, P>0.05; Figure 3, panels A, D, G and J). In old participants (n=9), SBP 248
and MAP were significantly lower following BR supplementation compared with PL (Figure 249
3, panels B and E). Changes between PL and BR (Δ) in MAP, SBP, and DBP between PL 250
and BR conditions inversely correlated with the change in plasma [NO2
-
] relative to NO3
-
251
dose per kg body mass (Δ[NO2-]/NO3 dose; Figure 3, panels C, F and I). BR supplementation 252
did not significantly alter radial-femoral PWV (Figure 3, panels J and K) across all 253
participants, but ΔPWV between BR and PL in the old participants (increase of 4.3 ± 10.9 254
m·s
-1
; n=9) was different (P<0.05) from ΔPWV in the young participants (decrease of -6.8 ± 255
9.8 m·s
-1
; n=9). ΔPWV positively correlated with Δ[NO2-]/NO3 dose (Figure 3L). Absolute 256
plasma [NO2
-
] or [NO3
-
] measured in the PL condition were not correlated with Δ[NO2-], 257
ΔDBP, ΔSBP, ΔMAP or Δ PWV. One old male participant did not wish to undertake PWV 258
measurement and therefore all PWV data are derived from 17 participants. 259
260
Tongue microbiome at baseline261
Relative abundances of the five main oral bacterial phyla in tongue swab samples collected at 262
baseline were Bacteroidetes 32 ± 9%, Fusobacteriales 27 ± 11%, Proteobacteria 20 ± 7%, 263
Firmicutes 17 ± 5% and Actinobacteria 1 ± 1 %. The most abundant bacterial species found 264
on the tongue were Fusobacterium nucleatum subsp. nucleatum (16 ± 8%), Prevotella 265
melaninogenica (14 ± 7 %), Campylobacter concisus (13 ± 8%), Leptorichia buccalis, (7 ± 266
6%) Veillonella parvula (5 ± 3%), Prevotella intermedia (4 ± 2%), Fusobacterium nucleatum 267
subsp. vincentii (3 ± 3%) and Neisseria meningitidis (3 ± 3%). Correlations between relative 268
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abundances of selected taxonomic units of tongue bacteria and physiological responses to BR 269
supplementation are shown in Table 2. The greatest decreases in BP were associated with 270
high abundances at baseline of Fusobacterium nucleatum subsp. vincentii and nucleatum, and 271
order Actinomycetales, whereas a high relative abundance of Prevotella melaninogenica was 272
associated with a greater mean score in SFR-Q, and smaller changes in plasma [NO2
-
], SBP 273
and PWV in response to BR supplementation (Table 2). 274
275
Saliva microbiome after PL and BR supplementation 276
Relative abundances of the main phyla of oral bacteria differed between PL and BR 277
conditions (Figure 4). Relative abundance of Proteobacteria was greater and Bacteroidetes 278
was lower following BR compared with PL (P<0.05), while abundances of Firmicutes and 279
Fusobacteria tended to be lower following BR supplementation compared with PL (P<0.10). 280
NMDS plots revealed that oral microbial communities differed significantly between PL and 281
BR supplemented conditions (Figure 5A), but there were no differences between young and 282
old participants (Figure 5B).  A Shannon diversity index revealed no significant differences 283
in species diversity between PL and BR conditions (Figure 6). Overall, 52 taxonomic units 284
were significantly different between BR and PL conditions. Figure 7 illustrates statistically 285
significant differences at genera and species levels between PL and BR. The trend for 286
reduction in the relative abundance of Firmicutes following BR was primarily due to a 287
decrease in Veillonella (-65%), including a 65% decrease in Veillonella parvula species (both 288
P<0.05), while the order Lactobacilliales and genus Streptococcus were not affected by BR 289
(P>0.05). Within the phylum Bacteroidetes, BR resulted in a reduction in the genus 290
Prevotella (-60%), and specifically P. melaninogenica (-67%) compared to PL (both 291
P<0.05). The increase in Proteobacteria after BR stemmed from an increase in the order 292
Neisseriales (+348%), containing the genus Neisseria (+351%) and N. meningitidis (+439%) 293
13 
(all P<0.05), while there were no statistically significant changes in the genera 294
Campylobacter or Haemophilus.  Proportions of the phylum Actinobacteria were not 295
significantly different between PL and BR, but there was an increase in the genus Rothia 296
(+127%, P<0.05) and R. mucilaginosa (+234%, P<0.05) after BR supplementation relative to 297
PL. There was insufficient microbial DNA in a saliva sample of one young male participant 298
and therefore the saliva microbiome data were for 17 participants. 299
300
Correlations across PL and BR conditions showed that plasma [NO3
-
] and [NO2
-
] positively 301
correlated with relative abundances of Rothia and Neisseria and inversely correlated with 302
Prevotella and Veillonella (Table 3). PWV positively correlated with relative abundance of 303
Rothia and R. mucilaginosa (Table 3).  304
305
Discussion 306
307
We used an in vivo experimental model and bacterial 16S rRNA gene sequencing to examine 308
relationships between the oral microbiome and physiological indices of NO bioavailability in 309
humans and changes in these variables following NO3
-
 supplementation. The principal 310
finding of this study was that dietary NO3
-
 supplementation altered the salivary microbiome 311
in young (~20 yrs) and old (~74 yrs) normotensive humans, such that it increased relative 312
abundances of some bacteria capable of NO3
-
reduction (Rothia and Neisseria) while reducing 313
the abundances of other NO3
-
 reducers (Prevotella and Veillonella). NO3
-
 supplementation 314
increased NO bioavailability in all participants, as indicated by plasma concentrations of 315
NO3
-
 and NO2
-
, and reduced systemic blood pressure in the old, but not young, participants. 316
Across placebo and NO3
-
 supplemented conditions, high abundances of Rothia and Neisseria317
and low abundances of Prevotella and Veillonella were associated with high NO 318
14 
bioavailability. The current findings indicate that the oral microbial community was 319
malleable to change with increased dietary intake of inorganic NO3
-
, and, importantly, that 320
the oral microbiome was related to indices of NO homeostasis and vascular health in vivo. 321
322
Relationships between the tongue microbiome at baseline and responsiveness to NO3
-
323
supplementation 324
It has been proposed that the oral microbiome modulates the magnitude of plasma [NO2
-
] 325
increase, and changes in associated physiological indices, in response to NO3
-
326
supplementation (Bryan et al. 2017; Hyde et al. 2014ab; Koch et al. 2016). A recent study 327
indicated that a composite relative abundance of seven species (including Prevotella 328
melaninogenica, Veillonella parvula, and Rothia mucilaginosa) was positively correlated 329
with the rise in salivary [NO2
-
], but not plasma [NO2
-
], in response to acute ingestion of a 330
single NO3
-
 bolus (Burleigh et al. 2018). We found that individuals who had high proportions 331
of P. melaninogenica and Campylobacter concisus at baseline were less responsive to 332
chronic NO3
-
 supplementation, i.e. had smaller increases in plasma [NO2
-
] and smaller or no 333
reductions in BP, than those individuals who had low abundances of P. melaninogenica and 334
C. concisus. In addition, a high mean SFR-Q score at baseline, which indicated more frequent 335
self-reported symptoms of dry mouth, was associated with greater abundance of Prevotella336
and a smaller increase in plasma [NO2
-
] in response to NO3
- 
supplementation. Campylobacter 337
concisus is believed to express dissimilatory NO3
-
 reduction to NH3 and its main 338
physiological function is NO2
-
 reduction (Simon & Klotz 2013), while P. melaninogenica has 339
been shown to encode NO2
-
, but not NO3
-
, reductase genes (Hyde et al. 2014b). It may, 340
therefore, be speculated that during subsequent NO3
-
 supplementation both C. concisus and 341
P. melaninogenica, which were dominant species in tongue swab samples at baseline, may 342
have acted as net consumers of NO2
-
 in the oral cavity. In contrast, high abundances of 343
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Fusobacterium nucleatum subspecies and Actinomycetales at baseline were associated with 344
greater increases in plasma [NO2
-
] and greater reductions in blood pressure in response to 345
NO3
-
 supplementation (Table 2). Actinomycetales are generally obligate anaerobes, and 346
includes several species such as Actinomyces odontolyticus and Actinomyces naeslundii that 347
have been identified as effective NO3
-
 reducers (Doel et al. 2005). Fusobacterium nucleatum 348
can reduce NO2
-
, but does not possess NO3
-
-reductase genes. However, F. nucleatum349
provides ‘scaffolding’ in biofilms, enabling microbial attachments (Kolenbrander et al. 350
2002), and it is possible that these bacteria may have facilitated attachment and proliferation 351
of key NO3
-
 reducing bacteria during subsequent dietary interventions.  352
353
Changes in the salivary microbiome after NO3
-
 supplementation  354
We showed that, relative to placebo, NO3
-
 supplementation altered the proportions of the 355
main oral microbial phyla by decreasing the Bacteroidetes and increasing the Proteobacteria. 356
At the genus level, NO3
-
 supplementation significantly increased relative abundances of the 357
previously identified NO3
-
 reducers Neisseria (Hyde et al. 2014b) and Rothia (Doel et al. 358
2005) in saliva. This was consistent with a report of a significant increase in N. flavescens359
and a trend for an increase in R. mucilaginosa in saliva samples of hypercholesterolaemic 360
patients after 6 weeks of NO3
-
 supplementation (Velmurugan et al. 2015). A novel finding in 361
the present study was that a high abundance of the facultative anaerobe R. mucilaginosa was 362
associated with faster pulse wave velocity, indicative of lower arterial stiffness. These data 363
suggest that high relative abundances of bacteria belonging to Neisseria and Rothia were 364
related to high NO bioavailability and may promote vascular health. 365
366
We also found that compared to placebo, NO3
-
 supplementation decreased relative 367
abundances of the obligate anaerobic bacteria Prevotella and Veillonella in saliva. This 368
16 
finding appears to contradict studies that have used in vitro approaches to identify key oral 369
NO3
-
 reducing taxa. Hyde et al. (2014b) categorised biofilms prepared from tongue swab 370
samples of six healthy humans as best, intermediate and worst NO3
-
 reducers and found 371
greater abundances of both Prevotella and Veillonella in the best versus worst NO3
-
 reducing 372
biofilms. Using tongue swab samples from ten healthy humans, which were incubated on 373
solid medium under aerobic and anaerobic conditions and analysed by 16S rDNA 374
sequencing, Doel et al. (2005) concluded that Veillonella were the most prevalent oral NO3
-
375
reducers and were major contributors to net NO2
-
 production. Intricate metabolic interactions 376
among the oral microbiota might mean that increased NO3
-
 availability in the oral cavity may 377
not facilitate the growth of all bacteria capable of NO3
-
 reduction. It is not directly apparent 378
why NO3
- 
supplementation resulted in a decline in Veillonella. One factor that may have 379
contributed to proliferation of some taxa and inhibition of others is the oral pH, which is a 380
powerful modulator of the oral microbial community. Beetroot juice supplementation has 381
been shown to increase oral pH from 7.0 to 7.5 (Hohensinn et al. 2016), and notably, a pH of 382
8 is optimal for NO3
-
 reductase activity (van Maanen et al. 1996). Monitoring of salivary pH 383
alongside alterations in the oral microbiome during NO3
-
 supplementation should be 384
undertaken in future studies to address the possible effects of pH. 385
386
Given that many oral bacteria with ability to reduce NO3
-
 are also capable of downstream 387
metabolism of the produced NO2
-
, it is important to differentiate between NO3
-
reducing 388
bacteria in general and NO2
-
 accumulating bacteria specifically. NO3
-
 reducing oral bacteria 389
have been identified in vitro from human samples, including Veillonella, Actinomyces, 390
Rothia, Staphylococcus and Propionibacterium (Dole et al. 2005). More recently Hyde et al. 391
(2014b) added Neisseria, Haemophilus parainfluenzae, Prevotalla (including P. 392
melaninogenica) and Granulicatella to the list of candidate species for most potent 393
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contributors to oral NO2
-
 production. We showed that some of the oral bacteria that have been 394
proposed as key NO2
-
 accumulators on the basis of in vitro experiments, such as Veillonella395
and Prevotella, do not thrive under high NO3
-
 availability in vivo. Indeed, we found no 396
significant changes in relative abundances of Actinomyces, Staphylococcus, 397
Propionibacterium, Granulicatella or Haemophilus after NO3
- 
supplementation. In order to 398
contribute significantly to the amount of NO2
-
 that is swallowed from the oral cavity, the 399
bacteria need to reduce NO3
-
 at a faster rate than they reduce NO2
-
, or not undertake 400
downstream metabolism of NO2
-
 at all. Overall, to maximise NO bioavailability from a NO3
-
401
-rich diet, the composition of the oral microbial community needs to be such that it contains a 402
greater quantity of net NO2
-
 accumulators than net NO2
-
 consumers. Further research is 403
needed to establish whether the observed microbiome changes following chronic NO3
-
404
supplementation in the present cohort, are replicated in different populations and whether 405
such changes are associated with an increased capacity for acute NO3
-
 reduction in the oral 406
cavity. 407
408
The present data suggest that the chronic (10-day) NO3
-
 supplementation serves to change the 409
relative abundance of a few, but not all, NO3
-
 reducing taxa and that these changes are 410
correlated with beneficial changes in NO bioavailability and indices of cardiovascular health. 411
It should be noted that elevated NO bioavailability may have further beneficial effects on 412
aspects of healthy ageing, including maintenance of a strong immune response. A recent 413
study showed that tongue microbiomes that had high abundances of Prevotella and 414
Veillonella species were associated with elevated risks of all-cause mortality and mortality 415
from pneumonia in frail elderly nursing home residents (Kageyama et al. 2017). NO3
- 
416
supplementation in older people, which reduces the relative abundances of Prevotella and 417
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Veillonella, may therefore have potential to enhance the NO-mediated immune response in 418
this high-risk population. 419
420
Differences in [NO2
-
] and blood pressure responses between young and old participants421
Previous studies have shown appreciable inter-individual variability in the plasma [NO2
-
] and 422
blood pressure responses to NO3
-
ingestion in both young and older populations (e.g. Casey et 423
al. 2015; Jaija et al. 2014; Kelly et al. 2013). We found that despite ingesting the same dose 424
of NO3
-
the old adults showed a greater plasma [NO2
-
] increase than the young adults, and 425
also exhibited a reduction in blood pressure which was absent in the young participants. The 426
magnitude of the BP response to NO3
-
supplementation is correlated with baseline blood 427
pressure (Kapil et al. 2013; Webb et al. 2008), such that in the present study the scope for a 428
BP decrease in the young adults, who had a BP of ~112/63 mmHg in placebo, was likely 429
small. Although the balance of evidence indicates that NO3
-
represents an potent dietary 430
means for reducing systemic BP (Bryan et al. 2017; Kapil et al. 2013 Koch et al. 2017; 431
Larsen et al. 2006; Webb et al. 2008), it is important to note that there are several studies that 432
concur with the present finding of not showing a significant change in resting systolic or 433
diastolic BP (or both) in young, healthy adults (e.g. Kelly et al. 2013b; Larsen et al. 2010; 434
McDonagh et al. 2015; Vanhatalo et al. 2014).435
436
Since the human vascular response to NO3
-
supplementation is dependent on efficient437
bacterial reduction of NO3
-
to NO2
-
, it is possible that at least some of this variability is linked 438
to differences between individuals in the oral microbiota and therefore oral NO3
-
reducing 439
capacity. NMDS analysis revealed no overall differences in the salivary microbiomes 440
between young and old participants, or following placebo or NO3
-
supplementation. The 441
greater responsiveness to supplementation in the old compared to young participants was 442
19 
surprising, given that ageing is typically associated with reduced salivary flow rate and 443
altered oral bacterial colonisation (Percival et al. 1991). It is important to note that although 444
the self-reported frequency of dry mouth symptoms was greater in the young adults, we did 445
not directly quantify salivary flow rate in this study, and agreement between self-reported 446
xerostomia questionnaire data and measured saliva secretion rate varies (Fox et al. 1987; 447
Lima et al. 2017; Malicka et al. 2014). We are therefore unable to determine whether the 448
higher occurrence of self-reported symptoms of dry mouth in the young adults was in fact 449
attributed to significantly lower salivary flow in comparison to the old adults. Whether 450
possible differences in salivary flow rate and/or NO3
-
uptake into the enterosalivary 451
circulation via sialin 2NO3
-
/H
+
transporters (Qu et al. 2016) contribute to inter-individual 452
variability in responsiveness to NO3
-
supplementation irrespective of age warrants further 453
investigation with large cross-sectional cohorts across the human lifespan. 454
455
Physical exercise and diet are emerging as powerful modulators of the gut microbiota (Barton 456
et al. 2017) and it is intuitive that the microbiota in the oral cavity, the uppermost section of 457
the alimentary canal, may also vary according to age, diet, and with physical activity levels. 458
There is evidence to suggest that the gut microbiome of healthy older people may be 459
remarkably similar to that of young adults (Bian et al. 2017), and that age-related alterations 460
in the gut microbiome may be related to advancing frailty and development of disease (Biagi 461
et al. 2010). Whether the maintenance of a ‘young’ gut microbiome into older age is a cause 462
or consequence of healthy ageing is unknown. Our data suggest that the oral microbiome of 463
individuals who have reached their 8
th
 decade of life without chronic disease is 464
indistinguishable from oral microbiome of young adults. The inclusion criteria in the present 465
study meant that the enrolled old participants were in exceptionally good health for their age 466
and therefore not representative of an ageing population with poor cardiovascular and/or 467
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metabolic health, who may be less responsive to NO3
-
 supplementation due to impairments in 468
NO bioactivity (Siervo et al. 2015). Indeed, we found that there was no difference in blood 469
pressure between young and old participants following NO3
-
 supplementation. Longitudinal 470
studies are necessary to identify possible changes that may occur in the oral microbiome, and 471
NO bioavailability, at the onset of chronic disease.  472
473
The dietary interventions in the present study consisted of twice daily ingestion of NO3
-
-rich 474
and NO3
-
-depleted beetroot juice concentrate that were matched for carbohydrate and 475
polyphenol content (Gilchrist et al. 2013). It should be noted that the alterations we observed476
in the salivary microbiome following NO3
-
-rich beetroot juice supplementation may be due to 477
NO3
-
alone or an additive effect of NO3
-
and other nutritional components of the beetroot 478
supplement. Elevated carbohydrate intake may have favoured the growth of those microbes 479
that use carbohydrate as an energy substrate at the expense of proteolytic bacteria, such as 480
Prevotella. Further studies using supplementation with salts of NO3
-
(KNO3, NaNO3) are481
warranted to ascertain the effect of NO3
-
alone on the oral microbiome. 482
483
Methodological considerations 484
Microbial analysis was performed on tongue swab samples at baseline and on saliva samples 485
following placebo and NO3
-
supplementation periods. Saliva samples represent a composite 486
of bacteria from all oral sites, while tongue swab samples target the tongue dorsum which 487
was shown to have the highest NO3
-
reductase activity by Doel et al. (2005). The quantities 488
and relative abundances of bacteria vary between different oral sites, such that potential 489
changes in microbiome assessed from tongue swabs following NO3
-
supplementation may 490
differ from those observed in the saliva samples in the present study. However, given the 491
similarities of findings on Neisseria and Rothia between the present study and that of 492
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Velmurugan et al. (2016), we are confident that the salivary microbiome analyses in the 493
present study captured representative and meaningful differences between conditions in the 494
NO3
-
reducing oral microbiome. A limitation of the current study was that saliva samples 495
could not be included at the beginning of each supplementation period, and the wash-out 496
period required for NO3
-
-induced changes in the oral microbiome to return to baseline 497
following cessation of supplementation is not known. Future work should include in vivo498
tests of oral NO3
-
reduction capacity to ascertain whether the changes in oral microbiome 499
following chronic NO3
-
supplementation are associated with enhanced oral NO3
-
reduction. In 500
the present study, we inferred enhanced oral NO3
-
reduction from plasma [NO2
-
]. Finally, 501
further investigation should target the optimisation of the dose and duration of prebiotic NO3
-
502
supplementation, and its possible interactions with the macronutrient content of the diet, to 503
provide maximal functional effects of NO3
-
supplementation.504
505
Conclusions 506
Imbalances in the oral microbial community and poor dental health have been associated with 507
reduced cardiovascular and metabolic health. We showed that ageing, per se, in the absence 508
of chronic disease, does not impair an individual’s ability to reduce dietary NO3- and increase 509
plasma [NO2
-
] in response to NO3
-
supplementation. Using 16S rRNA gene sequencing of 510
oral bacteria in an in vivo experimental model, we showed that high abundances of oral 511
bacteria belonging to genera Prevotella and Veillonella were likely detrimental, while high 512
abundances of the genera Rothia and Neisseria were likely beneficial for the maintenance of 513
NO homeostasis and associated indices of cardiovascular health. The symbiotic relationship 514
between the oral microbiome and its human host is a fast evolving field of research with 515
significant implications for development of prebiotic and probiotic interventions to improve 516
cardiovascular and metabolic health. Our results identify dietary NO3
-
as a modulator of the 517
22 
oral NO2
-
-producing microbiome in healthy humans and highlight the potential of oral 518
microbiota-targeted therapies for ameliorating conditions related to low NO bioavailability.519
520
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Figure legends 695
696
Figure 1 Participants underwent 10-day supplementation periods with nitrate (~12.4 mmol/d) 697
and placebo in a balanced cross-over design.  Screening, protocol familiarisation and Salivary 698
Flow Rate Questionnaires (SFR-Q) were completed at baseline. Measurements of plasma 699
nitrite (NO2
-
) and nitrate (NO3
-
) concentrations, blood pressure (BP) of the brachial artery, 700
arterial stiffness as carotid-femoral pulse wave velocity (PWV), and the collection of saliva 701
samples for microbiome analysis were undertaken on days 8, 9 and 10 of each 702
supplementation period. 703
704
Figure 2 Plasma [NO3
-
] (panel A) and [NO2
-
] (panel B) were significantly greater after 705
nitrate supplementation (white bars) compared to placebo (black bars) (n=18). The change 706
(Δ) in plasma [NO3-] between nitrate and placebo conditions was similar in young (n=9) and 707
old participants (n=9) (panel C), but Δ[NO2-] was significantly greater in the old compared to 708
young participants. Error bars indicate standard deviations and black squares (panels C and 709
D) indicate means for young and old participants. * P<0.05.  710
711
Figure 3 Mean arterial pressure (MAP; panel A), systolic blood pressure (SBP; panel D), 712
diastolic blood pressure (DBP; panel G) and pulse wave velocity (PWV; panel J) were not 713
different between placebo and nitrate conditions across all participants (n=18). The old 714
participants (n=9) showed greater reductions (Δ) in MAP, SBP and DBP between placebo 715
and nitrate conditions than the young participants (n=9; panels B, E and H), as well as a 716
greater increase in PWV (young n=9, old n=8; panel K). ΔMAP, ΔSBP and ΔDBP  inversely 717
correlated with the change in plasma [NO2
-
] relative to nitrate dose (Δ[NO2-]/NO3- dose) 718
32 
(panels C, F and I) and ΔPWV was positively correlated with Δ[NO2-]/NO3- dose (panel L). 719
*P<0.05. 720
721
Figure 4 The proportions of five main phyla of oral bacteria identified in the saliva samples 722
following placebo (PL) and NO3
-
 supplementation (BR). *Difference between PL and BR 723
(P<0.05). 724
725
Figure 5 Overall salivary microbiome composition illustrated by non-metric 726
multidimensional scaling (NMDS) analysis. The salivary microbiome composition was 727
different between nitrate (BR) and placebo (PL) conditions (P<0.05; panel A) but not 728
between young and old participants (P>0.05; panel B). 729
730
Figure 6 The Shannon diversity index indicated no statistically significant difference in 731
species diversity between nitrate (BR) and placebo (PL) conditions. 732
733
Figure 7 The genera (panels A and B) and species (panels C and D) that comprised >0.01% 734
of all bacteria and showed significant differences (P<0.05) between nitrate (BR) and placebo 735
(PL) conditions.  736
737
Table 1. Participant characteristics, nitrate (NO3
-
) dose and plasma [NO2
-
] responsiveness to 738
supplementation, and salivary flow rate questionnaire (SFR-Q) results. The young and old 739
participants were similar in terms of body mass and BMI. The NO3
-
 dose was similar in both 740
groups but old participants had a greater increase than the young in plasma [NO2
-
] in 741
response to supplementation. The young reported feeling more frequent symptoms of low 742
salivary flow rate than the old participants.  743
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744
Table 2. Correlation coefficients for relationships between selected taxonomic units of the 745
tongue microbiome (% of total bacteria) at baseline and subsequent changes between placebo 746
and  NO3
- 
supplementation in plasma [NO2
-
], blood pressure and arterial stiffness. PWV data 747
were not available for one old male participant, such that ΔPWV correlations are for n=17.748
Δ= change between placebo and NO3-; [NO2-]/NO3- dose = plasma [nitrite] relative to nitrate 749
dose per kg body mass ingested; DBP=diastolic blood pressure; SBP= systolic blood 750
pressure; MAP= mean arterial pressure; PWV= pulse wave velocity; SFR-Q= salivary flow 751
rate questionnaire; **P<0.01, *P<0.05, #P<0.10. 752
753
Table 3. Correlation coefficients for relationships between relative abundances of selected 754
taxonomic units of the salivary microbiome (% of total bacteria) and plasma [NO3
-
] and 755
[NO2
-
]; diastolic (DBP), systolic (SBP) and mean arterial (MAP) blood pressure; and pulse 756
wave velocity (PWV) across placebo and nitrate conditions. Saliva microbiome data were not 757
available for one young male participant and PWV data were not available for one old male 758
participant, such that [NO3
-
], [NO2
-
] and BP correlations are for n=34 and PWV correlations 759
are for n=32.  760
Table 1. Participant characteristics, nitrate (NO3
-
) dose and plasma [NO2
-
] 
responsiveness to supplementation, and salivary flow rate questionnaire (SFR-Q) 
results. The young and old participants were similar in terms of body mass and BMI. 
The NO3
-
 dose was similar in both groups but old participants had a greater increase 
than the young in plasma [NO2
-
] in response to supplementation. The young reported 
feeling more frequent symptoms of low salivary flow rate than the old participants. 
OLD
Sex Age
(yrs)
Body 
mass 
(kg)
BMI 
(kg/m
2
)
NO3
-
dose 
(mmol/kg/d)
Δ[NO2-]/NO3-
dose 
(nM/mmol/kg/d)
SFR-
Q 
mean 
score
1 F 77 88.0 33.1 0.14 7543 1.2
2 F 79 66.2 22.1 0.19 2325 1.3
3 F 70 60.0 24.3 0.21 2962 1.7
4 F 76 53.1 20.7 0.23 3942 1.1
5 F 72 51.4 20.1 0.24 4819 1.7
6 F 74 52.3 20.2 0.24 5428 1.9
7 M 78 88.8 31.1 0.14 812 2.0
8 M 70 78.6 25.4 0.16 5461 1.0
9 M 70 65.6 22.7 0.19 4829 1.5
Mean 74.0 67.1 24.4 0.19 4236 1.4
SD 3.6 14.8 4.7 0.04 1988 0.4
YOUNG
10 F 22 71.5 29.4 0.17 803 1.9
11 F 19 60.8 22.9 0.20 2202 2.5
12 F 19 64.5 22.6 0.19 880 1.6
13 F 20 69.7 24.4 0.18 1604 2.7
14 F 19 85.2 28.5 0.15 999 1.5
15 M 18 55.7 18.0 0.22 2371 1.5
16 M 22 81.2 23.7 0.15 3254 1.6
17 M 19 72.3 22.3 0.17 1127 2.1
18 M 19 84.4 26.0 0.15 70 2.1
Mean 19.7* 71.7 24.2 0.18 1479 * 2.0 *
SD 1.4 10.4 3.5 0.03 977 0.4
OVERALL (OLD + YOUNG)
Mean 46.8 69.4 24.3 0.18 2857 1.7
SD 28.1 12.6 4.0 0.03 2079 0.5
F, female; M, male; BMI, body mass index; Δ[NO2-]/NO3- dose, change in plasma 
[NO2
-
] relative to dose of NO3
-
 ingested per kg body mass; SFR-Q, salivary flow rate 
questionnaire; *Different from old, P<0.05. 
Table
Table 2. Correlation coefficients for relationships between selected taxonomic units of the tongue 
microbiome (% of total bacteria) at baseline and subsequent changes between placebo and  NO3
- 
supplementation in plasma [NO2
-
], blood pressure and arterial stiffness. PWV data were not 
available for one old male participant, such that ΔPWV correlations are for n=17.
Δ= change between placebo and NO3-; [NO2-]/NO3- dose = plasma [nitrite] relative to nitrate dose 
per kg body mass ingested; DBP=diastolic blood pressure; SBP= systolic blood pressure; MAP= 
mean arterial pressure; PWV= pulse wave velocity; SFR-Q= salivary flow rate questionnaire; 
**P<0.01, *P<0.05, #P<0.10. 
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Δ[NO2-]/NO3- dose -0.57* -0.73** -0.65** 0.65** -0.52*
A
c
ti
n
o
b
a
c
te
ri
a
Actinomycetales (order) 0.40 -0.39 -0.46 # -0.46 # 0.47 # -0.004
Micrococcales (order) -0.41 0.25 0.36 0.40 -0.21 -0.04
Rothia (genus) -0.20 0.10 0.32 0.37 -0.07 0.20
Rothia mucilaginosa -0.22 0.17 0.38 0.44 # -0.08 0.18
P
ro
te
o
b
a
c
te
ri
a Neisseria  (genus) 0.21 -0.06 0.06 0.29 0.59* -0.39
Neisseria meningitidis -0.09 -0.08 0.044 0.36 0.13 -0.19
Campylobacter concisus -0.55* 0.43 # 0.65** 0.34 -0.62** 0.30
B
a
c
te
ro
i-
d
e
te
s
Prevotella (genus) -0.49* 0.19 0.43 # 0.41 # -0.52* 0.51*
Prevotella melaninogenica -0.57* 0.16 0.53* 0.37 -0.68** 0.49*
F
ir
m
ic
u
te
s Veillonella (genus) -0.22 0.22 0.35 0.09 -0.02 0.46 #
Veillonella parvula -0.19 0.22 0.35 0.10 0.02 0.41 #
F
u
s
o
-
b
a
c
te
ri
a
Fusobacterium nucleatum 
subsp. nucleatum
0.44 # -0.17 -0.56* -0.30 0.32 -0.29
Fusobacterium nucleatum 
subsp. vincentii
0.55* -0.43 # -0.60** -0.63** 0.45 # -0.36
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Table 3. Correlation coefficients (r) for relationships between relative abundances of selected 
taxonomic units of saliva microbiome (% of total bacteria) and plasma nitrate ([NO3
-
]) and nitrite 
([NO2
-
]); diastolic (DBP), systolic (SBP) and mean arterial (MAP) blood pressure; and pulse wave 
velocity (PWV) across placebo and nitrate conditions. Microbiome data were not available for one 
young male subject and PWV data were not available for one older male subject, such that [NO3
-
], 
[NO2
-
] and BP correlations are for n=34 and PWV correlations are for n=32.  
DBP=diastolic blood pressure; SBP= systolic blood pressure; MAP= mean arterial pressure; PWV= 
pulse wave velocity; **P<0.01, *P<0.05, #P<0.10. 
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a
Actinomycetales (order) 0.25 0.09 -0.01 -0.09 -0.05 0.06
Micrococcales (order) 0.37 * 0.23 -0.03 0.02 0.00 0.48 **
Rothia (genus) 0.45 ** 0.30 # 0.04 0.03 0.04 0.45 *
Rothia mucilaginosa 0.46 ** 0.37 * 0.06 -0.03 -0.01 0.41 *
P
ro
te
o
b
a
c
te
ri
a Neisseria  (genus) 0.61 ** 0.64 ** 0.02 0.15 0.14 -0.13
Neisseria meningitidis 0.54 ** 0.53 ** -0.00 0.07 0.08 -0.23
Campylobacter concisus -0.26 -0.17 -0.17 0.08 0.02 0.42 *
B
a
c
te
ro
i-
d
e
te
s
Prevotella (genus) -0.47 ** -0.35 * 0.11 0.21 0.18 -0.18
Prevotella melaninogenica -0.47 ** -0.35 * 0.06 0.17 0.12 -0.09
F
ir
m
ic
u
te
s Veillonella (genus) -0.62 ** -0.50 ** -0.10 -0.01 -0.22 -0.07
Veillonella parvula -0.60 ** -0.49 ** -0.10 -0.03 -0.23 -0.08
F
u
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o
-
b
a
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te
ri
a
Fusobacterium nucleatum 
subsp. nucleatum
-0.28 -0.18 0.00 0.08 0.05 -0.10
Fusobacterium nucleatum 
subsp. vincentii
-0.16 -0.01 -0.03 0.12 0.07 -0.17
Table







Table S1. Barcode sequences for primers A and B.
Name Description Sequence (5ʹ to 3ʹ)
A_FW1 PCR to amplify 16s v1-v3 
amplicon (forward sequence)
CTCTTTCCCTACACGACGCTCTTCCG
ATCTAGAGTTTGATCCTGGCTCAG
A_RV1 PCR to amplify 16s v1-v3 
amplicon (reverse sequence)
CTGGAGTTCAGACGTGTGCTCTTCCG
ATCTGTATTACCGCGGCTGCTGG
B_FW1 PCR to attach Illumina 
flowcell binding nucleotides 
and identifying barcodes 
(forward sequence)
AATGATACGGCGACCACCGAGATCT
ACACTCTTTCCCTACACGACGCTCTT
CCGATCT
B_RV1 PCR to attach Illumina 
flowcell binding nucleotides 
and identifying barcodes 
(reverse sequence)
CAAGCAGAAGACGGCATACGAGATX
XXXXXXXXXXXGTGACTGGAGTTCA
GACGTGTGCTCTTCCGATCT *
* Adapter bar codes for tongue swab samples:
GGCCGGCTAGAT
GGACGGCATCTA
AAGGAAGGAGCG
GGACGGCGCTCG
CCGGACTCTCGA
GGCCGGCCGAGC
CCGGACTGAGCT
GGACGCGGCAGT
CCGGAGAAGTAA
GGCCGCGCGTCA
CCGGAGATCATT
CCGGATCCTTAT
CCGGATCGAATA
GGACCGGCCATG
GGACCGGTTGCA
GGACCAAGGCGG
CCGGTTGGTAGT
GGACCAATTATT
* Adapter bar codes for saliva samples:
CCCAGAGAGCAA
TCAGCATGCTGG
AGGAGTCAGCAA
AGTCGATGCTGG
GAAGATCAGCAA
GACTAATGCTGG
CTTCTTCAGCAA
CTGATATGCTGG
CTAGGTTGGCAA
CTCTGACACTGG
TCGAATTGGCAA
AGAGTACACTGG
GATCCTTGGCAA
TTCACTGACGGG
CCGTTAAGGCAA
AAGTGTGACTGG
TTACCAAGGCAA
ATCCAGTACGGG
TATTTCCGGCAA
TAGGTGTACCGG
ATAAACCGGTAA
CTAGAAGTCCGG
GAGATTACGTAA
GATCTAGTCCGG
AGAGCTACGGAA
TTGACCATGTGG
CCCTTGGCCCAA
GCATGACTGTGG
ATTAATTCCCAA
CGTACACTGTGG
GCCGGTTCCCAA
TTTCTCTAGTGG
CCAGCGCGCCAA
AAAGACTAGTGG
